The Board of BBI Life Sciences Corporation recommended the payment of a final dividend of HKD 0.012 per share for the year ended 31 December 2016, amounting to a total sum of approximately HKD 6,606,000 (approximately equivalent to RMB 5,909,000) to the shareholders. The final dividend is subject to the approval by the Shareholders at the forthcoming annual general meeting of the company to be held on 31 May 2017. The final dividend, if approved, is expected to be paid on, 30 June 2017 to the shareholders whose names appear on the register of members of the company on, 12 June 2017.